The clinical profile of NMOSD in Australia and New Zealand

Bukhari, W; Clarke, L; O'Gorman, C; Khalilidehkordi, E; Arnett, S; Prain, KM; Woodhall, M; Silvestrini, R; Bundell, CS; Ramanathan, S; Abernethy, D; Bhuta, S; Blum, S; Boggild, M; Boundy, K; Brew, BJ; Brownlee, W; Butzkueven, H; Carroll, WM; Chen, CL; Coulthard, A; Dale, RC; Das, C; Dear, K; Fabis-Pedrini, MJ; Fulcher, D; Gillis, D; Hawke, S; Heard, R; Henderson, APD; Heshmat, S; Hodgkinson, S; Jimenez-Sanchez, S; Kilpatrick, TJ; King, J; Kneebone, C; Kornberg, AJ; Lechner-Scott, J; Lin, MW; Lynch, C; Macdonnell, RAL; Mason, DF; McCombe, PA; Pereira, J; Pollard, JD; Reddel, SW; Shaw, C; Spies, J; Stankovich, J; Sutton, I; Vucic, S; Walsh, M; Wong, RC; Yiu, EM; Barnett, MH; Kermode, AG; Marriott, MP; Parratt, J; Slee, M; Taylor, BV; Willoughby, E; Wilson, RJ; Brilot, F; Vincent, A; Waters, P; Broadley, SA

Broadley, SA (corresponding author), Griffith Univ, Sch Med, Menzies Hlth Inst Queensland, Gold Coast Campus, Gold Coast, Qld 4222, Australia.; Broadley, SA (corresponding author), Gold Coast Univ Hosp, Dept Neurol, Southport, Qld 4215, Australia.

JOURNAL OF NEUROLOGY, 2020; 267 (5): 1431

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) are an inflammation of the central nervous system associated with autoantibodies to aquaporin-4. We ha......

Full Text Link